Gene · 2021
NIH grants944
NIH grants whose papers are about the gene, through NIH's grant-paper links.
601 to 620 of 944
Download this page as JSON| Grant | Title | ENDOG papers | Newest fiscal year |
|---|---|---|---|
| K99NS078049 | The role of a novel AIF-associated nuclease PAAN1 in neuronal injury | 1 | 2013 |
| P01AG030128 | ApoE Receptor Biology and Neurodegeneration | 1 | 2013 |
| P30NS047463 | VCU Neuroscience Center Core Grant | 1 | 2013 |
| R01AG011833 | Aging specific gene expression in Drosophila | 1 | 2013 |
| R01AG032042 | Role of APL-1, a C. elegans protein related to human amyloid precursor protein | 1 | 2013 |
| R01AG033373 | TOR, Translation and Aging | 1 | 2013 |
| R01AG036042 | Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences | 1 | 2013 |
| R01CA022762 | Role of Mitochondrial Respiratory Stress Signaling in Cancer Progression | 1 | 2013 |
| R01CA060664 | The in vivo role of the mitochondrial p53 cell death program | 1 | 2013 |
| R01CA085777 | DNA Repair and Replication Re-start in vivo | 1 | 2013 |
| R01CA100302 | In vivo function and mechanism of the r-protein-Mdm2-p53 pathway | 1 | 2013 |
| R01CA118005 | Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent | 1 | 2013 |
| R01CA127621 | Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia | 1 | 2013 |
| R01CA127770 | In vivo function of Mdm2 E3 ubiquitin ligase | 1 | 2013 |
| R01CA133662 | Novel Compounds to Inactivate Oncogenic Fusion Proteins | 1 | 2013 |
| R01CA136765 | Genetic determinants associated with pemetrexed response and toxicity | 1 | 2013 |
| R01CA152197 | Mechanism of Resistance to Arginine Deiminase Therapy in Advance Melanoma | 1 | 2013 |
| R01GM060911 | Regulation of caspase-9 | 1 | 2013 |
| R01GM062289 | Bax function in apoptosis | 1 | 2013 |
| R01GM063857 | ELECTROPORATION MECHANISM, MICRODOSIMETRY AND INCREASINGLY REALISTIC CELL MODELS | 1 | 2013 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2021/grants?page=31